Journal
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Volume 307, Issue 1, Pages 67-73Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/jpet.103.052506
Keywords
-
Categories
Funding
- NIAAA NIH HHS [AA12916] Funding Source: Medline
Ask authors/readers for more resources
Acetaminophen (AAP) overdose causes formation of peroxynitrite in centrilobular hepatocytes. Treatment with glutathione (GSH) after AAP accelerated recovery of mitochondrial GSH levels, which scavenged peroxynitrite and protected against liver injury at 6 h. The objective of this investigation was to evaluate whether GSH treatment has a long-term protective effect against AAP-induced injury and whether it promotes liver regeneration. AAP ( 300 mg/kg) induced severe centrilobular necrosis and increased plasma alanine aminotransferase (ALT) activities ( 24 h: 3680 +/- 320 U/liter) in fasted C3Heb/FeJ mice. Only 53% of the animals survived for 24 h. Hepatic glutathione levels were still suppressed by 62% at 24 h compared with untreated controls ( 19.7 +/- 2.6 mumol/g). Glutathione disulfide GSSG) concentrations were elevated by 455% compared with controls ( 74 +/- 3 nmol/g liver). Treatment with GSH at 1.5 h after AAP treatment attenuated liver necrosis and plasma ALT activities by 62 to 66% at 24 h. All animals survived up to 7 days. The hepatic GSH content recovered to control values; however, the GSSG levels were still elevated at 48 h ( 252 +/- 26 nmol/ g). Expression of proliferating cell nuclear antigen ( PCNA) and cell cycle proteins cyclin D 1 and p21 were not detectable in controls or after AAP alone. Treatment with GSH after AAP induced expression of cyclin D 1, p21, and PCNA ( 12 - 48 h). Thus, GSH treatment after AAP provided long-term hepatoprotection and promotes progression of cell cycle activation in hepatocytes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available